HIV Preexposure Prophylaxis in the Time of COVID-19: How a Robust and Responsive HIV Preexposure Prophylaxis Intervention Can Avert Loss of HIV Prevention Coverage During a Global Pandemic

J Acquir Immune Defic Syndr. 2021 May 1;87(1):e173-e176. doi: 10.1097/QAI.0000000000002652.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • COVID-19 / epidemiology*
  • Female
  • HIV Infections / prevention & control*
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • Pre-Exposure Prophylaxis / methods*
  • SARS-CoV-2 / isolation & purification
  • Young Adult

Substances

  • Anti-HIV Agents